In 2023, Australia became the first country in the world to allow health-care professionals to use a psychedelic drug to ...
One is a Cochrane review, published in January, that examined the literature on THC efficacy in treating chronic pain — ...
Solvonis Therapeutics PLC (LSE:SVNS), the LSE-listed biopharmaceutical company focused on central nervous system disorders, ...
The buyout, which includes another $525 million in floated payouts, hands Otsuka a medicine it sees as a possibly ...
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this ...
The Texas Tribune on MSN
Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help
The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for FDA approval.
The State of Texas will launch its own program to research a psychoactive drug called ibogaine after it was unable to find a ...
COLUMBUS, Ohio (WCMH) — Ohio lawmakers heard emotional testimony this week from several veterans, each describing how treatment with the psychedelic drug ibogaine helped them recover from ...
WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort ...
The psychedelic drug ibogaine is a Schedule I controlled substance, but Kentucky lawmakers are considering a bill researching ...
The country’s experiment with psychedelic medicine has led to positive outcomes, psychiatrists say, but also highlights the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results